EUCTR2017-000519-18-FR进行中(未招募)1 期
PIMOC : Personalized targeted therapies in inflammatory complex multi organ disease - PIMOC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •-Patients (men or women) aged 18 years old and over
- •-Patients presenting inflammatory non classified disease targeting at least 2 organs involvement: skin, lymph nodes, hemopoietic system, joints, digestive tract. Skin involvement is mandatory in order to be able to compare involved and non involved tissue
- •-Signed informed consent
- •The disease should be considered as non-classified despite classical and adapted investigations and evaluation through expert committee meeting.
- •The disease alters significantly quality of life using SF36 assessment : score less than 30.
- •The disease has been resistant to at least two prior lines of treatment.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 19
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 13
排除标准
- •-Patients presenting disease which is not featured by lesional and healthy skin areas, easy to biopsy
- •-Patients refusing biopsies
- •-Pregnancy
- •-Women of child-bearing potential unable to receive highly efficient contraception such as combined oral contraceptives, intra-uterine disposals, hormonal implants or the use of male condoms recommended in case of unstable or irregular partner or as a replacement method for transient unacessebility to hormonal method
- •-Breastfeeding
- •-Patients presenting disease needing urgent therapeutic measures
- •-Patients without health insurance or social security
- •-Patients under legal protection
- •-Participation in another interventional trial
- •-Patients unable to respect the wash out delay of previously taken medications before inclusion time :
- •*Hydroxychloroquine (wash out period = 30 days)
- •*Chloroquine (wash out period = 7 days)
- •*Colchicine (wash out period = 7 days)
- •*Methotrexate (wash out period = 7 days)
- •*Ciclosporine (wash out period = 14 days)
- •*Azathioprine (wash out period = 14 days)
- •*Mycophenolate mofetil (wash out period = 14 days)
- •*Disulone (wash out period = 7 days)
- •*Corticosteroids (=prednisone, prednisolone, dexamethasone, methylprednisolone) (wash out period = 7 days)
- •-Patients with contra-indications to treatments: Severe or active infections including tuberculosis
- •Importantly, in this study, the treatment will be selected by a committee depending on three criteria (cf Design of the trial: Interpretation of the data) including contra indications of the patients to the drugs. Therefore, contra indicated medications cannot be selected by the committee in view of protocol participation.
研究者
相似试验
进行中(未招募)
1 期
Application of intravenous lidocaïne and/or during surgery leads to a reduction of inflammation after breast cancer surgeryBreast cancer patients who undergo surgery for treatment.EUCTR2012-002222-70-NLniversity Medical Centre St Radboud48
已完成
4 期
Pilot study: Targeting the inflammatory response and the induction of acute pain after breast cancer surgery with perioperative infusion of lidocaineNL-OMON39927niversitair Medisch Centrum Sint Radboud16
撤回
不适用
ovel therapeutic targets and biomarkers in patients with Systemic Lupus Erythematosussystemic lupus erythematosusSLE10003816NL-OMON35524niversitair Medisch Centrum Utrecht62
招募中
不适用
prospective, observational registration studyfor women with Inflammatory breast cancerInflammatory Breast Cancer, INFLAME, IBCNL-OMON28954BOOG (the PI of the study is from University Medical Center Groningen)200
已完成
不适用
Development of a personalized immune-modulating therapy for patients with atopic dermatitis: evaluation of clinical efficacy of autologous immunoglobulin therapy for atopic dermatitis: a randomized, double-blind, placebo-controlled studyDiseases of the skin and subcutaneous tissueKCT0001597Ajou University Hospital51
